Avian Apocalypse Averted? "Miracle" Compound Boasts 100% Poultry Survival Against Deadly Respiratory Threats!
- Groundbreaking compound MGX-0024 shows 100% respiratory survival in large-scale poultry trials against severe diseases.
- Offers a natural, antibiotic-free defense using GRAS ingredients2, 3, with strong potential against Avian Flu (H5N1).
- Mangoceuticals (NASDAQ: MGRX) is fast-tracking this revolutionary solution to global markets, tackling a critical threat to food security.
A silent, airborne enemy is decimating poultry flocks worldwide. Respiratory diseases, including the notorious Newcastle Disease, Chronic Respiratory Disease (CRD), and the ever-looming specter of Avian Flu (H5N1), threaten not just birds, but potentially human health and global food supplies3. But in the face of this crisis, a stunning breakthrough from Mangoceuticals, Inc. heralds a new era of defense. Their patented compound, MGX-0024, has delivered an unprecedented 100% respiratory survival rate in recent poultry studies, signaling a powerful new weapon.
Conducted in India by Solice International, the field studies yielded astonishing results. In one trial involving 10,000 chicks, those treated with MGX-0024—simply administered through their drinking water—saw zero deaths from respiratory illnesses over 48 days2, 3. This was in stark contrast to an expected 50% mortality rate (5,000 deaths) based on losses at a nearby untreated control farm. An earlier study with 8,000 older chickens also showed a dramatic four-fold reduction in daily deaths from respiratory diseases compared to an untreated control group2, 3.
What makes MGX-0024 a game-changer? It’s a carefully crafted blend of natural polyphenols and zinc – ingredients Generally Recognized as Safe (GRAS) by health authorities2, 3. This all-natural, non-toxic formulation provides a potent shield without relying on vaccines or antibiotics, a critical advantage as global restrictions on antibiotic use in poultry farming tighten across India, the EU, and the US3.
"We believe that MGX-0024 is a safe, non-toxic, all natural, easy-to-use solution that could revolutionize poultry farming by keeping flocks healthy without the use of drugs or vaccines,” declared Jacob Cohen, Co-Founder and CEO of Mangoceuticals.
With further lab studies currently underway with Vipragen Biosciences and an Indian government laboratory to confirm its efficacy against the dreaded H5N1 avian flu2, Mangoceuticals is moving at lightning speed. The company is scaling production and engaging with regulatory bodies in the US, UK, Canada, and Australia, aiming to make MGX-0024 a frontline defense globally3. This isn't just about healthier chickens; it's about safeguarding our food chain and biosecurity. The fight against devastating avian plagues may have just found its champion.
References
Stay Updated!
Get the latest biotech and pharma news delivered to your inbox.